Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

TELUS CORP (TU)

As of 2026-11-20 · 10/15 boxes filled from SEC filings and market data

Report price $11.07 (close 2026-11-20)

Conclusion: WATCH

Conviction low · base case -58% · downside -70% · upside +10%

The market is paying 22.1x FY Dec 2025 net income of C$1.11B and 7.8x EV/EBITDA, a price that embeds +7.1% revenue growth a year for 10 years against +0.6% delivered in the fiscal year to 2025-12-31. The call is WATCH with low conviction, because the key numbers run only to 2025-12-31 and newer quarterly results exist. The base case is -57.5% at $4.71, a P/E of 9.4x, the peer median P/E. The downside is -70.2% at $3.30, the base case's multiple on -30.0% earnings. The upside is +10.0% at $12.18, +10% earnings at today's P/E of 22.1x. The three cases lean one way, but evidence that stops at the fiscal year-end, plus the unsolicited Québecor proposal and its unresolved regulatory questions, leaves the range open enough that low conviction is the honest setting and no stronger label is warranted.

Key numbers

  • Share price: $11.07
  • Market cap: $17.14B
  • Latest financial period: FY Dec 2025 to Dec 31, 2025
  • Revenue (FY Dec 2025): C$20.51B
  • EV / EBITDA (FY Dec 2025): 7.8x
  • P/E (FY Dec 2025): 22.1x
  • FCF yield: 8.7%
  • Price / book: 1.56x
  • EV / FCF (FY Dec 2025): 23.5x
  • Revenue growth (latest fiscal year): +0.6%
  • ROIC (FY Dec 2025): 3.4%
  • WACC: 4.2%
  • Economic profit spread: -0.7 pts

The 15 boxes

  1. ✓ 1. Long-form business notes

    TELUS CORP — which filed as TELUS CORPORATION until 2001-01-18 — is a Canadian communications company reporting TELUS technology solutions (mobile network, fixed data, health), TELUS Health and TELUS Digital; it files a 40-F, and all figures here are in CAD. FY2025 (year ended Dec 31, 2025) revenue was C$20.51B with operating income C$2.36B, net income C$1.11B and operating cash flow C$4.87B against capex C$2.73B. Revenue rose every year in the six-year window (C$15.46B in FY2020), but operating income did not follow — C$3.07B in FY2021 versus C$2.36B in FY2025 — as D&A rose from C$3.22B to C$4.06B. Between the oldest and newest annual periods the business was reshaped by acquisition and build: LifeWorks (Sept 1, 2022), WillowTree (Jan 3, 2023), Proagrica and Vumetric (2024), a 5G/fibre footprint of about 32.3M Canadians covered and more than 3.4M premises passed at Dec 31, 2024, and 3800 MHz spectrum bought in Nov 2023.

  2. ✓ 2. Competitive advantage

    The sources only let me measure the moat indirectly: revenue grew 32.7% from FY2020 (C$15.46B) to FY2025 (C$20.51B) but operating income fell from C$2.48B to C$2.36B and operating margin slid from 16.0% to 11.5% (both computed from the XBRL facts), so scale has not converted into pricing power or operating leverage in that window. Returns on equity were 7.0% in FY2025 versus 10.0% in FY2020 (computed on total equity), and the growth was funded with heavy capital spending (D&A C$4.06B on C$20.51B of FY2025 revenue, capex C$2.73B) plus a 20.1% increase in diluted shares from FY2020 to FY2025. The only real barriers visible in these sources are capital intensity and the regulatory/competitive disclosure the 40-F points to; it names no competitors and gives no subscriber, churn or licence detail here.

  3. ✓ 3. 10-Q takeaways

    Q3 2026 (three months ended September 30, 2026) operating revenues were $5,020M, down 1% from $5,067M, with service revenue $4,481M and equipment revenue $539M. The quarter swung to a $660M net loss and $0.42 basic loss per share after an $800M non-cash TELUS Health goodwill impairment; adjusted net income was $251M (-32%) and adjusted EBITDA $1,760M (-5%). Free cash flow fell 35% to $396M as capex rose 8%, cash was $1,308M at September 30, 2026 versus $2,621M at December 31, 2025, and net debt/EBITDA was 3.6x. The release reaffirmed full-year 2026 guidance and gave multi-year targets of about $900M annualized cash savings exiting 2028 and 3.0x or lower leverage by year-end 2028.

  4. ○ 4. Corporate governance
  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ○ 9. Insider trading interpretation
  10. ○ 10. Earnings-call notes
  11. ○ 11. Impression of the shareholder letter
  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans